References
- Park EJ, Jang JY, Lee JE, et al. The risk factors for bleeding of fundal varices in patients with liver cirrhosis. Gut Liver. 2013;7:704–711.
- Wu Q, Shen L, Chu J, et al. Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis. Oncol Lett. 2015;9:347–350.
- Wang QM, Ji Q, Duan ZJ, et al. A study on the position and etiology of infection in cirrhotic patients: a potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med. 2013;6:584–590.
- Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20:7312–7324.
- Romero-Gomez M, Ampuero J. Deciphering the spectrum of low-grade hepatic encephalopathy in clinical practice. Gastroenterology. 2014;146:887–890.
- Amodio P, Del PF, Petteno E, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol. 2001;35:37–45.
- Saito M, Seo Y, Yano Y, et al. Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. J Gastroenterol. 2012;47:704–714.
- Liu F, Cai LY, Zhong L, et al. Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis. J Dig Dis. 2010;11:352–357.
- Davis CJ, Sowa D, Keim KS, et al. The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. JPEN J Parenter Enteral Nutr. 2012;36:197–204.
- Rocha JC, Almeida MF, Carmona C, et al. The use of prealbumin concentration as a biomarker of nutritional status in treated phenylketonuric patients. Ann Nutr Metab. 2010;56:207–211.
- Boopathy R, Rajesh RV, Darvesh S, et al. Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity. Clin Chim Acta. 2007;380:151–156.
- Ostergaard D, Viby-Mogensen J, Hanel HK, et al. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand. 1988;32:266–269.
- Ramachandran J, Sajith KG, Priya S, et al. Serum cholinesterase is an excellent biomarker of liver cirrhosis. Trop Gastroenterol. 2014;35:15–20.
- Domingos MA, Moreira SR, Gomez L, et al. Urinary retinol-binding protein: relationship to renal function and cardiovascular risk factors in chronic kidney disease. Plos One. 2016;11:e162782.
- Chaves GV, Peres WA, Goncalves JC, et al. Vitamin A and retinol-binding protein deficiency among chronic liver disease patients. Nutrition. 2015;31:664–668.
- Tacke F, Weiskirchen R, Trautwein C. Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis. Hepatology. 2008;48:1724–1725.
- Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
- Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification. Hepatology. 2002;35:716–721.
- Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.
- Holecek M. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy. Nutrition. 2015;31:14–20.
- Romero-Gomez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62:437–447.
- Cordoba J, Minguez B. Hepatic encephalopathy. Semin Liver Dis. 2008;28:70–80.
- Balakrishnan CH, Rajeev H. Correlation of serum prolactin level to child pugh scoring system in cirrhosis of liver. J Clin Diagn Res. 2017;11:30–33.
- Attallah AM, Omran D, Omran MM, et al. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci. 2018;75:19–23.
- Lee J, Kim MY, Kang SH, et al. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection. Br J Biomed Sci. 2018;75:128–132.
- Yang D, Xie Y, Pan H, et al. Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome. Hepatol Res. 2017;47:1174–1185.
- Djiambou-Nganjeu H. Hepatic encephalopathy in liver cirrhosis. J Transl Int Med. 2017;5:64–67.
- Ampuero J, Montoliú C, Simón-Talero M, et al. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. J Gastroen Hepatol. 2018;33:718–725.